A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure

Project: Research

Project Details

Project Description


AcronymSEQUOIA
StatusActive
Effective start/end date17/06/2016/06/25

Keywords

  • Clinical trial
  • phase 3 study
  • treatment efficacy
  • treatment safety
  • Parkinson's disease